<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00370955</url>
  </required_header>
  <id_info>
    <org_study_id>8527</org_study_id>
    <nct_id>NCT00370955</nct_id>
  </id_info>
  <brief_title>The Effect of Hydrodynamic Parameters on Corneal Endothelial Cell Loss After Phacoemulsification</brief_title>
  <official_title>The Effect of Hydrodynamic Parameters on Corneal Endothelial Cell Loss After Phacoemulsification</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shahid Beheshti University of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shahid Beheshti University of Medical Sciences</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare two surgical techniques (high vacuum and low vacuum)&#xD;
      on corneal endothelium after phacoemulsification.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients aged 50 to 70 years old with moderate lens opacities (nuclear sclerosis of 3+) were&#xD;
      included. The exclusion criteria were: 1-previous corneal pathology (dystrophic or&#xD;
      degenerative such as Fuchs' endothelial dystrophy or advanced trachoma), 2- pseudoexfoliation&#xD;
      syndrome (PEX), 3- history of intra ocular surgery, 4- glaucoma or ocular hypertension, 5-&#xD;
      eyes with a history of anterior uveitis, 6- diabetes mellitus, 7- anterior chamber depth&#xD;
      (ACD) less than 2.5 mm or more than 4 mm, 8- axial length less than 21 mm or more than 25 mm,&#xD;
      9- density of endothelial cells less than 1500 cells per mm2, 10- polymegatism (CV &gt; 0.4),&#xD;
      11- keratometric astigmatism more than 1.5 Diopters (D), 12- history of contact lens usage,&#xD;
      13- Intra-operative complications (posterior capsule rupture with or without vitreous loss),&#xD;
      14- postoperative uveitis, 15- postoperative surgical wound leakage, 16- deep-set eye, and&#xD;
      17- size of dilated pupil less than 6 mm. Nucleus density was evaluated using the LOCS III&#xD;
      classification system Patients were divided in 2 groups randomly: Group 1 included those&#xD;
      candidates for phacoemulsification using high hydrodynamic parameter: 400 mmHg vacuum and 40&#xD;
      ml/min flow rate (high vacuum technique) whereas group 2 consisted of patients who underwent&#xD;
      phacoemulsification using low hydrodynamic parameters: 200 mmHg vacuum and 20 ml/min flow&#xD;
      rate (low vacuum technique). All surgeries were performed by one surgeon using stop and chop&#xD;
      technique with sovereign (white star technology) (AMO, USA). During sculpting stage, vacuum&#xD;
      was 40mmHg and flow rate is 20ml/min, in both groups. Irrigation aspiration of cortical&#xD;
      material and viscoelastic were bimanually and semi automatically performed with flow rate of&#xD;
      30ml/min.&#xD;
&#xD;
      Total ultrasound power and total volume of BSS in both groups were measured. Pachymetry,&#xD;
      endothelial cell density, polymegathism, before and 1, 6 and 12 weeks after intervention were&#xD;
      also evaluated. Statistically analysis of data included univariate (student t-test and x2)&#xD;
      and multivariate (regression model) analysis of postoperative results.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2007</start_date>
  <completion_date type="Actual">December 2007</completion_date>
  <primary_completion_date type="Actual">August 2007</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total ultrasound energy dissipated to the eye, total infused fluid, Endothelial cell loss</measure>
    <time_frame>All patients were examined on postoperative day 1 and weeks 1, 6 and 12.</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Cataract</condition>
  <arm_group>
    <arm_group_label>High vacuum group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Those patients who underwent phacoemulsification using high hydrodynamic parameter: 400 mmHg vacuum and 40 ml/min flow rate.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low vacuum group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients who underwent phacoemulsification using low hydrodynamic parameters: 200 mmHg vacuum and 20 ml/min flow rate.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>phacoemulsification using either high vacuum or low vacuum techniques</intervention_name>
    <description>All surgeries were performed using Sovereign phacoemulsification system (AMO) using Whitestar technology.</description>
    <arm_group_label>High vacuum group</arm_group_label>
    <arm_group_label>Low vacuum group</arm_group_label>
    <other_name>stop and chop technique</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria were:&#xD;
&#xD;
          -  Moderate lens opacity (Nuclear sclerosis 3+)&#xD;
&#xD;
          -  Age between 50 to 70 years&#xD;
&#xD;
        The exclusion criteria were:&#xD;
&#xD;
          -  Previous corneal pathology (dystrophic or degenerative such as Fuchs' endothelial&#xD;
             dystrophy or advanced trachoma),&#xD;
&#xD;
          -  Pseudoexfoliation syndrome (PEX),&#xD;
&#xD;
          -  History of intra ocular surgery,&#xD;
&#xD;
          -  Glaucoma or ocular hypertension,&#xD;
&#xD;
          -  Eyes with a history of anterior uveitis,&#xD;
&#xD;
          -  Diabetes mellitus,&#xD;
&#xD;
          -  Anterior chamber depth (ACD) less than 2.5 mm or more than 4 mm,&#xD;
&#xD;
          -  Axial length less than 21 mm or more than 25 mm,&#xD;
&#xD;
          -  Density of endothelial cells less than 1500 cells per mm2,&#xD;
&#xD;
          -  Polymegatism (CV &gt; 0.4),&#xD;
&#xD;
          -  Keratometric astigmatism more than 1.5 Diopters (D),&#xD;
&#xD;
          -  History of contact lens usage,&#xD;
&#xD;
          -  Intra-operative complications (posterior capsule rupture with or without vitreous&#xD;
             loss),&#xD;
&#xD;
          -  Postoperative uveitis,&#xD;
&#xD;
          -  Postoperative surgical wound leakage,&#xD;
&#xD;
          -  Deep-set eye, and 17- size of dilated pupil less than 6 mm.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alireza Baradaran Raffiee, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ophthalmic Research Center of Shaheed Beheshti Medical University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Alireza Baradaran Raffiee</name>
      <address>
        <city>Tehran</city>
        <zip>16666</zip>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <link>
    <url>http://www.orcir.org/english/Default.aspx</url>
    <description>Official webpage of ophthalmic research center of Shahid Beheshti University of Medical Sciences</description>
  </link>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/pubmed/19304097?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&amp;ordinalpos=2</url>
    <description>Published article</description>
  </link>
  <verification_date>October 2008</verification_date>
  <study_first_submitted>August 31, 2006</study_first_submitted>
  <study_first_submitted_qc>August 31, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 1, 2006</study_first_posted>
  <last_update_submitted>December 24, 2009</last_update_submitted>
  <last_update_submitted_qc>December 24, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 25, 2009</last_update_posted>
  <responsible_party>
    <name_title>Ophthalmic Research Center of Shaheed Beheshti Medical University</name_title>
    <organization>Shaheed Beheshti Medical University</organization>
  </responsible_party>
  <keyword>Phacoemulsification</keyword>
  <keyword>Corneal endothelial cell loss</keyword>
  <keyword>Hydrodynamic parameters</keyword>
  <keyword>Total ultrasound energy</keyword>
  <keyword>Total infused fluids</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
    <mesh_term>Corneal Endothelial Cell Loss</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

